首页> 美国卫生研究院文献>Leukemia Research Reports >Central nervous system post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience
【2h】

Central nervous system post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience

机译:同种异体造血干细胞移植后中枢神经系统移植后淋巴增生性疾病:长崎移植组的经验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 17-year-old male received allogeneic transplantation for acute lymphoblastic leukemia, and presented with generalized seizures due to a solitary brain lesion with massive necrosis on day +621. Epstein–Barr virus (EBV) DNA copies were below the cut-off value in plasma. Stereotactic biopsy of the cerebral lesion confirmed the diagnosis of post-transplant lymphoproliferative disorder (PTLD) with large atypical cells positive for CD20 and EBER. In order to diagnose primary central nervous system PTLD, the biopsy should be applied as early as possible when brain lesion with necrosis develops in post-transplant patients regardless of EBV-DNA in plasma.
机译:一名17岁的男性因急性淋巴细胞白血病接受了同种异体移植,由于在孤立的第621天出现严重的坏死性孤立性脑部病变而出现全身性癫痫发作。爱泼斯坦-巴尔病毒(EBV)DNA拷贝数低于血浆中的临界值。脑病变的立体定向活检证实了对移植后淋巴组织增生性疾病(PTLD)的诊断,该疾病具有CD20和EBER阳性的大型非典型细胞。为了诊断原发性中枢神经系统PTLD,无论血浆中EBV-DNA为何,当移植后患者出现脑坏死并伴有坏死时,应尽早进行活检。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号